Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: scandinavian cohort study
Since GLP-1s were first approved for weight loss and the market took off, there has been significant concern about the relatively high rate of loss of lean body mass, particularly muscle, especially as compared with traditional weight loss techniques
Pierre-Louis: Are there other sort of unexpected potential benefits that theyre seeing from these drugs
R.Ben-JosefE.et al (2004)
US$ 28.82
US$ 20.07
US$ 22.21
US$ 21.13
US$ 25.76
US$ 29.86
